Remarkably, treatment with NECA significantly increased PD-L1 expression on CLL cells, an effect further exacerbated when cells were co-treated with IL-10 or IFN-γ (Figure 5A,B). This evidence concerns the gene IL10 and B-cell chronic lymphocytic leukemia.